Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer care.
From Days to Hours: MicroGenDX Ushers in Next-Day NGS Results ORLANDO, FLORIDA / ACCESS Newswire / July 7, 2025 / MicroGenDX, a national leader in molecular diagnostics, announces the integration of ...
NATICK, Mass.--(BUSINESS WIRE)--Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to ...
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing (NGS) assay for genetic analysis of thalassemia and sickle cell disease (SCD) available on the Europ ...
To permanently access this eBook for free, fill out the short form below. Ready to revolutionise your molecular testing for myeloid malignancies? With a constantly expanding list of biomarkers, ...
Patients with classic NF1 including the presence of cutaneous neurofibromas or Lisch nodules, as no genetic heterogeneity demonstrated so far associated with this phenotype. The NF1-only by NGS ...
MENLO PARK, Calif., Oct. 30, 2018 /PRNewswire-PRWeb/ -- Clear Labs, the only automated and intelligent NGS platform purpose-built for food safety testing, today announced the close of $21M in funding.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that the New York State Department of Health (NYSDOH) has granted the ...
Tissue inadequacy and operational challenges may limit lung cancer comprehensive biomarker testing. Here, we describe the initial implementation of a tailored tissue molecular journey at Oncoclínicas ...
Molecular pathology represents a subspecialty within pathology that is focused on interpretation of complex molecular and genomic tests. This discipline has only recently emerged, further reducing the ...
Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer LOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Biodesix, ...
Patients with multiple schwannomas w/wo vestibular schwannomas. This testing approach is developed to diagnose mosaic NF2, classic NF2, Schwannomatosis, and mosaic schwannomatosis. The Meningiomatosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results